[go: up one dir, main page]

WO1994011518A3 - Methods for converting a, ab, and b blood types to o blood type - Google Patents

Methods for converting a, ab, and b blood types to o blood type Download PDF

Info

Publication number
WO1994011518A3
WO1994011518A3 PCT/US1993/010794 US9310794W WO9411518A3 WO 1994011518 A3 WO1994011518 A3 WO 1994011518A3 US 9310794 W US9310794 W US 9310794W WO 9411518 A3 WO9411518 A3 WO 9411518A3
Authority
WO
WIPO (PCT)
Prior art keywords
acetylgalactosaminidase
blood
converting
methods
types
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1993/010794
Other languages
French (fr)
Other versions
WO1994011518A2 (en
Inventor
Randy M Berka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Danisco US Inc
Original Assignee
Genencor International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genencor International Inc filed Critical Genencor International Inc
Priority to EP94901346A priority Critical patent/EP0668920A1/en
Priority to JP6512285A priority patent/JPH08503137A/en
Publication of WO1994011518A2 publication Critical patent/WO1994011518A2/en
Publication of WO1994011518A3 publication Critical patent/WO1994011518A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01049Alpha-N-acetylgalactosaminidase (3.2.1.49)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/18Erythrocytes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A process for producing α-N-acetylgalactosaminidase by expressing a DNA sequence derived from human placenta encoding α-N-acetylgalactosaminidase in a recombinant host microorganism transformed with an expression vector containing DNA sequence and isolating transformants having α-N-acetylgalactosaminidase expression. The isolated transformants are then cultured and α-N-acetylgalactosaminidase is purified from the culture media. The recombinantly produced α-N-acetylgalactosaminidase is used to convert A, B and AB blood types into O blood type.
PCT/US1993/010794 1992-11-18 1993-11-08 Methods for converting a, ab, and b blood types to o blood type Ceased WO1994011518A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP94901346A EP0668920A1 (en) 1992-11-18 1993-11-08 Methods for converting a, ab, and b blood types to o blood type
JP6512285A JPH08503137A (en) 1992-11-18 1993-11-08 Method for converting A, AB and B blood to O blood

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97794592A 1992-11-18 1992-11-18
US07/977,945 1992-11-18

Publications (2)

Publication Number Publication Date
WO1994011518A2 WO1994011518A2 (en) 1994-05-26
WO1994011518A3 true WO1994011518A3 (en) 1994-11-10

Family

ID=25525671

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1993/010794 Ceased WO1994011518A2 (en) 1992-11-18 1993-11-08 Methods for converting a, ab, and b blood types to o blood type

Country Status (4)

Country Link
EP (1) EP0668920A1 (en)
JP (1) JPH08503137A (en)
CA (1) CA2149641A1 (en)
WO (1) WO1994011518A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2159083C (en) * 1993-03-26 2002-07-02 Alex Zhu Recombinant .alpha.-n-acetylgalactosaminidase enzyme and cdna encoding said enzyme
JPWO2019131505A1 (en) * 2017-12-26 2021-01-21 国立大学法人徳島大学 Protein transfer method for filamentous fungal cells and its products
US12103222B2 (en) 2018-12-21 2024-10-01 The Curators Of The University Of Missouri Methods and systems for drawn fused filament fabrication printing

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992007936A1 (en) * 1990-10-24 1992-05-14 The Mount Sinai School Of Medicine Of The City University Of New York Cloning and expression of biologically active alpha-n-acetylgalactosaminidase

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992007936A1 (en) * 1990-10-24 1992-05-14 The Mount Sinai School Of Medicine Of The City University Of New York Cloning and expression of biologically active alpha-n-acetylgalactosaminidase

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
WANG A. ET AL.: "Human alpha-N-acetylgalactosaminidase-molecular cloning, nucleotide sequence, and expression of a full-length cDNA", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 265, no. 35, December 1990 (1990-12-01), BALTIMORE, MD US, pages 21859 - 21866, XP002256779 *
YAMAUCHI TOYOAKI ET AL.: "Molecular cloning of two species of cDNAs for human alph-N-acetylgalactosaminidase and expression in mammalian cells", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 170, no. 1, 16 July 1990 (1990-07-16), DULUTH, MINNESOTA US, pages 231 - 237, XP001312681 *

Also Published As

Publication number Publication date
WO1994011518A2 (en) 1994-05-26
CA2149641A1 (en) 1994-05-26
EP0668920A1 (en) 1995-08-30
JPH08503137A (en) 1996-04-09

Similar Documents

Publication Publication Date Title
AU586855B2 (en) Insulin precursors, process for their preparation and process for the preparation of human insulin
AU572353B2 (en) Transformation of yeasts of the genus pichia
IL115834A0 (en) Process for bacterial production of polypeptides
GB8610600D0 (en) Transformation of trichoderma
CA2099841A1 (en) Expression of recombinant proteins in attenuated bacteria
EP0343783A3 (en) Method for producing cells containing stably integrated foreign dna at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign dna
WO1998014602A3 (en) Preparation of d-amino acids by direct fermentative means
EP0505311A3 (en) A process for producing heme proteins
AU5445098A (en) Methods for producing polypeptides in surfactin mutants of bacillus cells
EP0248637A3 (en) Induction of galactose regulated gene expression in yeast
KR840008697A (en) Method for Synthesis, Secretion and Expression Media of Heterologous Proteins Using Homologous Yeast Signals
AU621810B2 (en) Amylolytic enzymes producing microorganisms, constructed by recombinant DNA technology and their use for fermentation processes
GR880300088T1 (en) Amylolytic enzymes producing microorganisms constructed by recombinant dna technology and their use for fermentation processes
AU2085195A (en) Gene coding for igg-fc-binding protein
WO1994011518A3 (en) Methods for converting a, ab, and b blood types to o blood type
AU6279390A (en) Multi-functional enzymes including derivable 2',3'-didesoxyribofuranoside triphoshpates
EP0555475A4 (en) Process for producing 4-hydroxy-l-proline
GR3016996T3 (en) Method for the preparation of a protein by yeast using an inductible system, vectors and corresponding transformed strains.
MY103364A (en) Synthetic porcine growth hormone
AU8045294A (en) Methods for producing protein C
EP0169006A3 (en) Genetically modified micro-organisms
EP0422217A4 (en) Human recombinant placental ribonuclease inhibitor and method of production
ATE107959T1 (en) CLONING THE GENE ENCODING ISOAMYLASE ENZYME AND ITS USE IN THE PRODUCTION OF SUCH ENZYME.
CA2064774A1 (en) Culture methods for producing activated protein c
EP0322084A3 (en) Tumor cell inhibition factor

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2149641

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1994901346

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1994901346

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1994901346

Country of ref document: EP